Preclinical models have demonstrated that the CXCL13/CXCR5 axis is crucial for promoting intra-tumour T-cell migration (Figure 4), and accordingly, tumours with high CXCL13 expression exhibit an increased infiltration of activated CD8+ CXCR5+ T-cells. The gene discussed is CXCR5; the disease is neoplasm.